Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Sofia Syed's research investigates the connections between chemotherapy, the gut microbiome, and cognitive function. Her work examines how treatments like doxorubicin, cyclophosphamide, and paclitaxel impact the composition of the gut microbiome and subsequently influence cognition. This research utilizes animal models to study disease progression and potential interventions. Syed has published 19 scholarly works, which have been cited 785 times, and holds an h-index of 3. She collaborates with researchers at the University of Arkansas for Medical Sciences, including Michael Scott Robeson, Antiño R. Allen, Beth Cronin, and Christa Corley, with whom she has co-authored publications.
Metrics
- h-index: 3
- Publications: 19
- Citations: 785
Selected Publications
-
Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment (2026)
Collaboration Network
Top Collaborators
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
Similar Researchers
Based on overlapping research topics